DOSE OF REALITY: GENERIC AND BIOSIMILAR COMPETITION GENERATES SIGNIFICANT SAVINGS FOR PATIENTS AND THE U.S. HEALTH CARE SYSTEM
Report Underscores How Competition Lowers Prescription Drug Prices by… Read More

Report Underscores How Competition Lowers Prescription Drug Prices by… Read More
Patent Abuse Blocked Competition From More Affordable Alternatives For Periods… Read More
Highest Priced Brand Name Treatments Showcase Big Pharma’s Rising Launch… Read More
The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big… Read More
Analysis Underscores How Anti-Competitive Tactics Like Patent Thicketing Keep… Read More
Big Pharma is at it again, working overtime to pass a policy that would cost… Read More
Reuters Analysis Finds Prices for Drugs First Entering the Market More Than… Read More
Novo Nordisk Alone Has Filed 320 Patents on Single Active Ingredient Behind… Read More
Brand Name Drug Companies Increase Prices By More Than Rate of Inflation in… Read More
Lawmakers Should Pass Bipartisan, Market-Based Solutions to Crack Down on… Read More
CBO Confirms Cost of Blockbuster Obesity Drugs at Current Prices Would… Read More
STAT Analysis Finds Drug Makers Gaming FDA Orange Book Process to Further… Read More